Lumos Diagnostics, a spinout from Planet Innovation, merged with RPS Diagnostics in May 2019, are a complete solution provider for rapid point-of-care diagnostics solutions. It helps you develop and manufacture custom rapid Point-of-Care diagnostic solutions.
Lumos Diagnostics delivers custom diagnostic solutions by combining deep market insight with existing platform technologies, assay development capability and regulated manufacturing experience.
Lumos Diagnostics was founded in 2017 and is headquartered in Sarasota, Florida, with an office in Carlsbad, California.
Lumos Diagnostics is creating a diverse healthcare company that combines the FebriDx test and commercial experience with a novel and proprietary digital reader platform.a diverse healthcare company that combines the FebriDx test and commercial experience with a novel and proprietary digital reader platform.
Lumos Diagnostics provides rapid, cost-effective and complete point-of-care (POC) diagnostic test solutions that utilize proprietary digital reader platforms to help healthcare professionals more accurately diagnose and manage diseases and medical conditions.
Lumos Diagnostics has raised $15M in a Series A round on Feb 05, 2020. The investment is backed by Planet Innovation, an Australia-based healthtech innovation and commercialization company, made the investment.